Extracorporeal photochemotherapy (ECP) is a procedure effective in the treatment of several human T-cell mediated diseases. During ECP treatment the patient’s blood is processed by means of a cell separator to collect leukocytes (leukapheresis), mostly lymphocytes and monocytes (PBMC), which are then added with the photoactive drug 8-methoxypsoralen (8-MOP), exposed to ultraviolet-A light (UV-A) and reinfused into the patient. Even if the mechanisms of action of ECP remain elusive, it has been shown that it has an in-vivo immunomodulatory effect in experimental ellergic encephalomyelitis (EAE) and in a small pilot study in multiple sclerosis (MS) patients. It has been suggested that during ECP not only UV-A irradiation but also the environmental condition changes may be relevant, an aspect which has never been investigated in detail. Therefore, we developed a new bench device which reliably mimics ex-vivo the complete ECP cycle and we investigated the effect of 8-MOP, UV-A and their combination on the synthesis of IFN-gamma, IL-2 and TNF-alpha on healthy controls and a MS patient. PBMC were collected and treated with 8-MOP and/or UV-A under the same conditions used for the ECP therapy. PBMC were polyclonally stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin in the presence of Brefeldin A (BFA) to prevent newly synthesized cytokine egression. Intracellular pro-inflammatory cytokines produced by activated T-lymphocytes were evaluated. We observed a significant decrease in activated CD4+ and CD8+ T-lymphocytes producing cytokines after UV-A irradiation and a further decrease in the presence of 8-MOP + UV-A. The decrease in cytokines production seemed to be both cytokine- and cell type-related. In fact TNF-alpha production was reduced to a lesser extent than IFN-gamma and IL-2 ones by both UV-A and the co-treatment, while CD4+ T-cells seemed to be more sensitive than CD8+ lymphocytes when IFN-gamma and IL-2 production was considered. Both T-cell population showed similar behaviour when TNF-alpha production was evaluated. 8-MOP and UV-A co-treatment affected T-lymphocytes activation after polyclonal stimulation and. reduced IFN-gamma, IL-2 and TNF-alpha production with different extent among the cytokines considered. Following this preliminary experience this ex-vivo protocol will be used to extend the determinations in the EAE model and to reproduce these observations in a larger series of healthy controls and MS patients.

Rigolio, R., Perseghin, P., Petersson, J., Jonsson, S., Biffi, A., Cavaletti, G., et al. (2006). Ex-vivo study of extracorporeal photochemotherapy effects on immune system: early experience in healthy controls and a multiple sclerosis patient.. In Abstract Book (pp.63-63).

Ex-vivo study of extracorporeal photochemotherapy effects on immune system: early experience in healthy controls and a multiple sclerosis patient.

RIGOLIO, ROBERTA
Primo
;
CAVALETTI, GUIDO ANGELO
Penultimo
;
2006

Abstract

Extracorporeal photochemotherapy (ECP) is a procedure effective in the treatment of several human T-cell mediated diseases. During ECP treatment the patient’s blood is processed by means of a cell separator to collect leukocytes (leukapheresis), mostly lymphocytes and monocytes (PBMC), which are then added with the photoactive drug 8-methoxypsoralen (8-MOP), exposed to ultraviolet-A light (UV-A) and reinfused into the patient. Even if the mechanisms of action of ECP remain elusive, it has been shown that it has an in-vivo immunomodulatory effect in experimental ellergic encephalomyelitis (EAE) and in a small pilot study in multiple sclerosis (MS) patients. It has been suggested that during ECP not only UV-A irradiation but also the environmental condition changes may be relevant, an aspect which has never been investigated in detail. Therefore, we developed a new bench device which reliably mimics ex-vivo the complete ECP cycle and we investigated the effect of 8-MOP, UV-A and their combination on the synthesis of IFN-gamma, IL-2 and TNF-alpha on healthy controls and a MS patient. PBMC were collected and treated with 8-MOP and/or UV-A under the same conditions used for the ECP therapy. PBMC were polyclonally stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin in the presence of Brefeldin A (BFA) to prevent newly synthesized cytokine egression. Intracellular pro-inflammatory cytokines produced by activated T-lymphocytes were evaluated. We observed a significant decrease in activated CD4+ and CD8+ T-lymphocytes producing cytokines after UV-A irradiation and a further decrease in the presence of 8-MOP + UV-A. The decrease in cytokines production seemed to be both cytokine- and cell type-related. In fact TNF-alpha production was reduced to a lesser extent than IFN-gamma and IL-2 ones by both UV-A and the co-treatment, while CD4+ T-cells seemed to be more sensitive than CD8+ lymphocytes when IFN-gamma and IL-2 production was considered. Both T-cell population showed similar behaviour when TNF-alpha production was evaluated. 8-MOP and UV-A co-treatment affected T-lymphocytes activation after polyclonal stimulation and. reduced IFN-gamma, IL-2 and TNF-alpha production with different extent among the cytokines considered. Following this preliminary experience this ex-vivo protocol will be used to extend the determinations in the EAE model and to reproduce these observations in a larger series of healthy controls and MS patients.
Si
abstract + poster
Scientifica
Extracorporeal Photochemotherapy, multiple sclerosis, T lymphocyte cytokine production
English
XVI Associazione Italiana Neuroimmunologia (AINI) Congress
Rigolio, R., Perseghin, P., Petersson, J., Jonsson, S., Biffi, A., Cavaletti, G., et al. (2006). Ex-vivo study of extracorporeal photochemotherapy effects on immune system: early experience in healthy controls and a multiple sclerosis patient.. In Abstract Book (pp.63-63).
Rigolio, R; Perseghin, P; Petersson, J; Jonsson, S; Biffi, A; Cavaletti, G; Cilio, C
File in questo prodotto:
File Dimensione Formato  
2006 AINI Ostuni Rigolio.PDF

accesso aperto

Descrizione: Abtract
Dimensione 17.44 MB
Formato Adobe PDF
17.44 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/60864
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact